RBC Capital analyst Arun Viswanathan lowered the firm’s price target on Chemours (CC) to $17 from $19 and keeps an Outperform rating on the shares after its Q3 earnings miss. The stock saw a positive reaction to the quarter but remains down over 25% YTD as pricing pressure remains in TiO2, and operational upsets in Advanced Performance Materials are offsetting gains in Thermal & Specialized Solutions, the analyst tells investors in a research note.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC: